indicating possible bidirectional ephrin-B2–EphB4 signaling in lymphangiogenesis. VEGF-blocking antibodies or tyrosine kinase inhibitors are routinely used in people suffering from cancer.
The biology and physiology of the lymphatic and blood vascular systems including vascular regeneration, remodeling and pathology Vascular biomaterials, including polymeric, natural, and metallic, for ...
Michael Jeltsch: Lymphangiogenesis Research and Antibody Development We do biomedical research in vascular biology (lymphangiogenesis, VEGF-C) and antibody technology development. Anne Juppo and Mia ...
Path. Soc. Jan 2006. Kumar, P., et al., Angiogenesis and lymphangiogenesis in testicular germ cell tumours (TGCT). Path. Soc. 2006 Parachaney, P., et al., The effect of intrauterine growth restriction ...